Aetiology, pathogenesis, and pathology of cervical neoplasia

MJ Arends, CH Buckley and M Wells
Department of Pathology, University of Edinburgh, Medical School, UK.

Early epidemiological studies of cervical neoplasia suggested a causal relation with sexual activity and human papillomaviruses (HPVs) have emerged as prime suspects as venerally transmitted carcinogens. HPVs fall into two broad camps: low risk types, associated with cervical condylomas and CIN 1; and high risk types (mostly 16 and 18), found in 50-80% of CIN 2 and CIN 3 lesions, and 90% of cancers. This association with cancer is very strong, with odds ratios of > 15 (often much higher) in case-control studies that are methodologically sound. An infrequently detected third group of intermediate risk type HPVs is associated with all grades of CIN and occasionally with cancers. HPVs have also been detected in a wide range of asymptomatic controls, indicating that other events are required for development of neoplasia such as viral persistence and/or altered expression of viral genes, often following integration of the viral genome. This leaves the two major viral oncogenes, E6 and E7, directly coupled to viral enhancers and promoters, allowing their continued expression after integration. High risk HPV E7 proteins bind and inactivate the Rb protein, whereas E6 proteins bind p53 and direct its rapid degradation. A range of putative cofactors has been implicated in progression: HLA type, immunosuppression, sex steroid hormones, and smoking; most of these cofactors appear to influence progression to CIN 3. The natural history includes progression to CIN 3 in 10% of CIN 1 and 20% of CIN 2 cases, whereas at least 12% of CIN 3 cases progress to invasive carcinoma. Cervical glandular intraepithelial neoplasia (CGIN) often coexists with squamous CIN, and the premalignant potential of high grade CGIN is not in doubt, but the natural history of low grade CGIN remains uncertain. A high proportion of CGIN lesions and adenocarcinomas are HPV positive, and HPV18 has been implicated more in glandular than in squamous lesions. A strong clinical case for the application of HPV typing of cells recovered from cervical scrapes can be made; however, a rigorous cost-benefit analysis of introducing HPV typing into the cervical screening programme is required. Prophylactic and therapeutic HPV vaccines are under development. This article reviews the aetiology, pathogenesis, and pathology of cervical neoplasia, emphasising the role of HPVs.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Weaver, B. A. (2006). Epidemiology and Natural History of Genital Human Papillomavirus Infection. JAOA: Journal of the American Osteopathic Association 106: S2-S8 [Abstract] [Full Text]  
• Someya, M., Sakata, K.-i., Matsumoto, Y., Yamamoto, H., Monobe, M., Ikeda, H., Ando, K., Hosoi, Y., Suzuki, N., Hareyama, M. (2006). The association of DNA-dependent protein kinase activity with chromosomal instability and risk of cancer. Carcinogenesis 27: 117-122 [Abstract] [Full Text]  
• Bravaccini, S, Sanchini, M A, Amadori, A, Medri, L, Saragoni, L, Calistri, D, Monti, F, Volpi, A, Amadori, D (2005). Potential of telomerase expression and activity in cervical specimens as a diagnostic tool. J. Clin. Pathol. 58: 911-914 [Abstract] [Full Text]  
• Pett, M. R., Alazawi, W. O. F., Roberts, I., Dowen, S., Smith, D. I., Stanley, M. A., Coleman, N. (2004). Acquisition of High-Level Chromosomal Instability Is Associated with Integration of Human Papillomavirus Type 16 in Cervical Keratinocytes. Cancer Res. 64: 1359-1368 [Abstract] [Full Text]  
• Brandlein, S., Beyer, I., Eck, M., Bernhardt, W., Hensel, F., Muller-Hermelink, H. K., Vollmers, H. P. (2003). Cysteine-rich Fibroblast Growth Factor Receptor 1, a New Marker for Precancerous Epithelial Lesions Defined by the Human Monoclonal Antibody PAM-1. Cancer Res. 63: 2052-2061 [Abstract] [Full Text]  
• Alazawi, W., Pett, M., Arch, B., Scott, L., Freeman, T., Stanley, M. A., Coleman, N. (2002). Changes in Cervical Keratinocyte Gene Expression Associated with Integration of Human Papillomavirus 16. Cancer Res. 62: 6959-6965 [Abstract] [Full Text]  
• Kenny, D., Shen, L.-P., Kolberg, J. A. (2002). Detection of Viral Infection and Gene Expression in Clinical Tissue Specimens Using Branched DNA (bDNA) In Situ Hybridization. J. Histochem. Cytochem. 50: 1219-1227 [Abstract] [Full Text]  
• Graham, D A, Herrington, C S (2000). HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities. Mol. Pathol. 53: 201-206 [Abstract] [Full Text]  
• Gudas, J. M., Payton, M., Thukral, S., Chen, E., Bass, M., Robinson, M. O., Coats, S. (1999). Cyclin E2, a Novel G1 Cyclin That Binds Cdk2 and Is Aberrantly Expressed in Human Cancers. Mol. Cell. Biol. 19: 612-622 [Abstract] [Full Text]